October 12, 2026Stocks·Neutral·biotech
Humacyte says interim Phase 3 data for ATEV in dialysis access to be presented Oct 22; sBLA filing expected this quarter
Humacyte says interim Phase 3 data for ATEV in dialysis access will be presented October 22, and expects to file an sBLA this quarter.
Detected & updated continuously · Source: Nebula
Story subjects